Literature DB >> 16679412

Sverdlovsk revisited: modeling human inhalation anthrax.

Dean A Wilkening1.   

Abstract

Several models have been proposed for the dose-response function and the incubation period distribution for human inhalation anthrax. These models give very different predictions for the severity of a hypothetical bioterror attack, when an attack might be detected from clinical cases, the efficacy of medical intervention and the requirements for decontamination. Using data from the 1979 accidental atmospheric release of anthrax in Sverdlovsk, Russia, and limited nonhuman primate data, this paper eliminates two of the contending models and derives parameters for the other two, thereby narrowing the range of models that accurately predict the effects of human inhalation anthrax. Dose-response functions that exhibit a threshold for infectivity are contraindicated by the Sverdlovsk data. Dose-dependent incubation period distributions explain the 10-day median incubation period observed at Sverdlovsk and the 1- to 5-day incubation period observed in nonhuman primate experiments.

Entities:  

Mesh:

Year:  2006        PMID: 16679412      PMCID: PMC1564296          DOI: 10.1073/pnas.0509551103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores.

Authors:  H A DRUETT; D W HENDERSON; L PACKMAN; S PEACOCK
Journal:  J Hyg (Lond)       Date:  1953-09

2.  Bacterial invasion.

Authors:  H A DRUETT
Journal:  Nature       Date:  1952-08-16       Impact factor: 49.962

3.  Discussion.

Authors:  H N Glassman
Journal:  Bacteriol Rev       Date:  1966-09

4.  The distribution of incubation periods of infectious disease.

Authors:  P E SARTWELL
Journal:  Am J Hyg       Date:  1950-05

5.  The Sverdlovsk anthrax outbreak of 1979.

Authors:  M Meselson; J Guillemin; M Hugh-Jones; A Langmuir; I Popova; A Shelokov; O Yampolskaya
Journal:  Science       Date:  1994-11-18       Impact factor: 47.728

6.  PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims.

Authors:  P J Jackson; M E Hugh-Jones; D M Adair; G Green; K K Hill; C R Kuske; L M Grinberg; F A Abramova; P Keim
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

7.  Modelling the incubation period of anthrax.

Authors:  Ron Brookmeyer; Elizabeth Johnson; Sarah Barry
Journal:  Stat Med       Date:  2005-02-28       Impact factor: 2.373

Review 8.  Information on which to base assessments of risk from environments contaminated with anthrax spores.

Authors:  A Watson; D Keir
Journal:  Epidemiol Infect       Date:  1994-12       Impact factor: 2.451

9.  The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak.

Authors:  R Brookmeyer; N Blades; M Hugh-Jones; D A Henderson
Journal:  Biostatistics       Date:  2001-06       Impact factor: 5.899

Review 10.  Systematic review: a century of inhalational anthrax cases from 1900 to 2005.

Authors:  Jon-Erik C Holty; Dena M Bravata; Hau Liu; Richard A Olshen; Kathryn M McDonald; Douglas K Owens
Journal:  Ann Intern Med       Date:  2006-02-21       Impact factor: 25.391

View more
  21 in total

1.  A dynamic dose-response model to account for exposure patterns in risk assessment: a case study in inhalation anthrax.

Authors:  Bryan T Mayer; James S Koopman; Edward L Ionides; Josep M Pujol; Joseph N S Eisenberg
Journal:  J R Soc Interface       Date:  2010-11-10       Impact factor: 4.118

2.  Finding leading indicators for disease outbreaks: filtering, cross-correlation, and caveats.

Authors:  Ronald M Bloom; David L Buckeridge; Karen E Cheng
Journal:  J Am Med Inform Assoc       Date:  2006-10-26       Impact factor: 4.497

Review 3.  A review of back-calculation techniques and their potential to inform mitigation strategies with application to non-transmissible acute infectious diseases.

Authors:  Joseph R Egan; Ian M Hall
Journal:  J R Soc Interface       Date:  2015-05-06       Impact factor: 4.118

4.  Structural models used in real-time biosurveillance outbreak detection and outbreak curve isolation from noisy background morbidity levels.

Authors:  Karen Elizabeth Cheng; David J Crary; Jaideep Ray; Cosmin Safta
Journal:  J Am Med Inform Assoc       Date:  2012-10-04       Impact factor: 4.497

5.  Modeling inhalational tularemia: deliberate release and public health response.

Authors:  Joseph R Egan; Ian M Hall; Steve Leach
Journal:  Biosecur Bioterror       Date:  2011-11-01

6.  Deterministic models of inhalational anthrax in New Zealand white rabbits.

Authors:  Bradford Gutting
Journal:  Biosecur Bioterror       Date:  2014-02-14

7.  Recommendations for modeling disaster responses in public health and medicine: a position paper of the society for medical decision making.

Authors:  Margaret L Brandeau; Jessica H McCoy; Nathaniel Hupert; Jon-Erik Holty; Dena M Bravata
Journal:  Med Decis Making       Date:  2009-07-15       Impact factor: 2.583

8.  Inhalation anthrax: dose response and risk analysis.

Authors:  Margaret E Coleman; Brandolyn Thran; Stephen S Morse; Martin Hugh-Jones; Stacey Massulik
Journal:  Biosecur Bioterror       Date:  2008-06

9.  Pathology and pathophysiology of inhalational anthrax in a guinea pig model.

Authors:  Vladimir Savransky; Daniel C Sanford; Emily Syar; Jamie L Austin; Kevin P Tordoff; Michael S Anderson; Gregory V Stark; Roy E Barnewall; Crystal M Briscoe; Laurence Lemiale-Biérinx; Sukjoon Park; Boris Ionin; Mario H Skiadopoulos
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

Review 10.  Inhaled therapeutics for prevention and treatment of pneumonia.

Authors:  Amar Safdar; Samuel A Shelburne; Scott E Evans; Burton F Dickey
Journal:  Expert Opin Drug Saf       Date:  2009-07       Impact factor: 4.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.